Ranked #1,747 of 8,699 institutional investors
Eversept Partners, LP
New York, NY
$1.61B
US stock portfolio at live prices · today −$23.2M (−1.42%)
Market closed. Prices as of Nov 20, 7:41 AM ET
- Value at quarter end (Q3 2026)
- $1.73B
- Change from Q2 2026
- −$99.6M (−5.43%)
- Positions
- 98 · 19 new, 26 sold out
- Filed
- Nov 16, 2026
Not counted in the ranking: put options on $125M. $50.8M of holdings we could not match to a US listing are included at their reported quarter-end value.
Holdings
Q3 2026 13F, live pricesUTHR 11.3%EHC 8.88%ENSG 7.95%ABVX 5.50%RVTY 4.23%
| Stock | Shares | Value, live | % of portfolio | vs Q2 2026 |
|---|---|---|---|---|
| UTHR United Therapeutics Corporation | 324,729 | $182M | 11.3% | Added +13% |
| EHC Encompass Health Corporation | 1,082,316 | $143M | 8.88% | Added +5% |
| ENSG The Ensign Group, Inc. | 726,186 | $128M | 7.95% | Added +21% |
| ABVX ABIVAX Société Anonyme | 1,100,655 | $88.8M | 5.50% | Added +20% |
| RVTY Revvity, Inc. | 449,790 | $68.2M | 4.23% | Added +438% |
| VERA Vera Therapeutics, Inc. | 2,361,996 | $63.2M | 3.92% | Added +7% |
| CTRE CareTrust REIT, Inc. | 1,352,628 | $50.1M | 3.11% | Added +26% |
| OHI Omega Healthcare Investors, Inc. | 1,008,565 | $46.3M | 2.87% | Added +109% |
| GH Guardant Health, Inc. | 256,430 | $37.3M | 2.32% | New |
| NTRA Natera, Inc. | 128,126 | $37.1M | 2.30% | Reduced −27% |
| LQDA Liquidia Corporation | 641,986 | $36.4M | 2.25% | Added +50% |
| WAT Waters Corporation | 75,422 | $34.4M | 2.13% | New |
| CLDX Celldex Therapeutics, Inc. | 1,174,771 | $32.8M | 2.04% | Reduced −34% |
| HCA HCA Healthcare, Inc. | 68,317 | $31.4M | 1.95% | Reduced −30% |
| PCVX Vaxcyte, Inc. | 509,239 | $29.7M | 1.84% | Reduced −19% |
| VKTX Viking Therapeutics, Inc. | 1,006,292 | $26.0M | 1.61% | Added +67% |
| BKD Brookdale Senior Living Inc. | 2,867,143 | $24.9M | 1.55% | Reduced −16% |
| CHE Chemed Corporation | 43,905 | $24.2M | 1.50% | Reduced −16% |
| INSM Insmed Incorporated | 160,810 | $23.2M | 1.44% | Added +8% |
| SNDX Syndax Pharmaceuticals, Inc. | 2,443,056 | $22.3M | 1.38% | Reduced −13% |
| TVTX Travere Therapeutics, Inc. | 453,866 | $21.9M | 1.36% | Reduced −43% |
| LTC LTC Properties, Inc. | 457,995 | $19.4M | 1.20% | Added +9% |
| GRAL GRAIL, Inc. | 182,154 | $19.1M | 1.18% | New |
| BMRN BioMarin Pharmaceutical Inc. | 304,843 | $18.7M | 1.16% | Added +22% |
| THC Tenet Healthcare Corporation | 70,419 | $18.6M | 1.15% | Reduced −38% |
| PNTG The Pennant Group, Inc. | 536,051 | $18.3M | 1.13% | Added +16% |
| BRKR Bruker Corporation | 279,854 | $17.4M | 1.08% | Added +53% |
| GERN Geron Corporation | 18,527,499 | $16.9M | 1.05% | Reduced −1% |
| GDRX GoodRx Holdings, Inc. | 5,019,604 | $15.2M | 0.94% | New |
| CYH Community Health Systems, Inc. | 9,138,106 | $14.7M | 0.91% | Added +16% |
| PODD Insulet Corporation | 100,970 | $13.9M | 0.86% | Reduced −32% |
| BBNX Beta Bionics, Inc. | 1,023,872 | $13.6M | 0.85% | Reduced −18% |
| COGT Cogent Biosciences, Inc. | 480,111 | $13.3M | 0.83% | Reduced −2% |
| WELL Welltower Inc. | 46,186 | $11.2M | 0.70% | Reduced −47% |
| RGEN Repligen Corporation | 64,819 | $11.0M | 0.68% | Added +350% |
| RLAY Relay Therapeutics, Inc. | 681,711 | $10.8M | 0.67% | Added +57% |
| TARS Tarsus Pharmaceuticals, Inc. | 129,279 | $10.0M | 0.62% | Added +132% |
| PACS PACS Group, Inc. | 211,736 | $9.1M | 0.56% | Added +80% |
| RARE Ultragenyx Pharmaceutical Inc. | 484,053 | $8.3M | 0.52% | Added +214% |
| MOH Molina Healthcare, Inc. | 39,385 | $8.0M | 0.50% | Reduced −51% |
| ANAB AnaptysBio, Inc. | 154,921 | $7.3M | 0.46% | Added +121% |
| CTMX CytomX Therapeutics, Inc. | 3,544,163 | $7.3M | 0.45% | Reduced −0% |
| ARWR Arrowhead Pharmaceuticals, Inc. | 156,219 | $6.8M | 0.42% | New |
| BCRX BioCryst Pharmaceuticals, Inc. | 865,137 | $6.3M | 0.39% | Reduced −54% |
| UNH UnitedHealth Group Incorporated | 19,160 | $6.3M | 0.39% | Reduced −63% |
| SNDA Sonida Senior Living, Inc. | 193,155 | $6.1M | 0.38% | Added +88% |
| VRDN Viridian Therapeutics, Inc. | 180,258 | $5.7M | 0.35% | Reduced −78% |
| SMMT Summit Therapeutics Inc. | 526,646 | $5.6M | 0.35% | New |
| CRVS Corvus Pharmaceuticals, Inc. | 503,017 | $5.0M | 0.31% | Reduced −33% |
| BNTX BioNTech SE | 61,667 | $5.0M | 0.31% | New |
| VOR Vor Biopharma Inc. | 268,389 | $5.0M | 0.31% | Added +79% |
| NHI National Health Investors, Inc. | 70,387 | $4.3M | 0.27% | Reduced −0% |
| ARDX Ardelyx, Inc. | 1,305,473 | $4.0M | 0.25% | Reduced −22% |
| LBRX LB Pharmaceuticals Inc | 92,850 | $3.7M | 0.23% | Reduced −49% |
| ANRO Alto Neuroscience Inc | 127,781 | $3.4M | 0.21% | Reduced −0% |
| IONS Ionis Pharmaceuticals, Inc. | 121,732 | $3.3M | 0.21% | Reduced −82% |
| ALEC Alector, Inc. | 1,418,233 | $3.3M | 0.20% | Reduced −0% |
| PALI Palisade Bio, Inc. | 3,474,548 | $3.2M | 0.20% | Reduced −17% |
| XENE Xenon Pharmaceuticals Inc. | 76,129 | $2.9M | 0.18% | Reduced −61% |
| BEAM Beam Therapeutics Inc. | 129,036 | $2.7M | 0.17% | Reduced −22% |
| MLYS Mineralys Therapeutics, Inc. | 189,949 | $2.7M | 0.17% | Reduced −39% |
| ABCL AbCellera Biologics Inc. | 254,116 | $2.7M | 0.16% | New |
| GPCR Structure Therapeutics Inc. | 155,127 | $2.7M | 0.16% | Reduced −21% |
| PMVP PMV Pharmaceuticals, Inc. | 1,964,624 | $2.6M | 0.16% | Added +4% |
| INO Inovio Pharmaceuticals, Inc. | 1,381,201 | $2.4M | 0.15% | Added +33% |
| LTGO Latigo Biotherapeutics, Inc. | 172,999 | $2.3M | 0.14% | New |
| EMBC Embecta Corp. | 350,463 | $2.2M | 0.13% | New |
| CTNM Contineum Therapeutics, Inc. | 199,602 | $1.8M | 0.11% | Added +35% |
| STIM Neuronetics, Inc. | 1,402,548 | $1.7M | 0.11% | New |
| AMRN Amarin Corporation plc | 144,816 | $1.6M | 0.10% | Reduced −0% |
| SPRB Spruce Biosciences, Inc. | 39,840 | $1.6M | 0.10% | Reduced −0% |
| SPRY ARS Pharmaceuticals, Inc. | 449,165 | $1.5M | <0.1% | Added +19% |
| ISRG Intuitive Surgical, Inc. | 3,684 | $1.5M | <0.1% | Reduced −49% |
| EQ Equillium, Inc. | 1,294,446 | $1.4M | <0.1% | Reduced −15% |
| TECH Bio-Techne Corporation | 19,308 | $1.4M | <0.1% | Unchanged |
| VIR Vir Biotechnology, Inc. | 155,992 | $1.4M | <0.1% | Reduced −0% |
| GRCE Grace Therapeutics, Inc. | 769,772 | $1.3M | <0.1% | Reduced −0% |
| KRYS Krystal Biotech, Inc. | 4,187 | $1.3M | <0.1% | New |
| NXTC NextCure, Inc. | 185,455 | $1.3M | <0.1% | New |
| UNCY Unicycive Therapeutics, Inc. | 336,000 | $1.2M | <0.1% | New |
| IVVD Invivyd, Inc. | 2,228,290 | $994K | <0.1% | Reduced −0% |
| WHWK Whitehawk Therapeutics, Inc. | 303,171 | $946K | <0.1% | Unchanged |
| RLMD Relmada Therapeutics, Inc. | 291,905 | $908K | <0.1% | Added +213% |
| AVR Anteris Technologies Global Corp. | 166,229 | $846K | <0.1% | Unchanged |
| EDIT Editas Medicine, Inc. | 456,923 | $781K | <0.1% | Reduced −0% |
| CTKB Cytek Biosciences, Inc. | 104,271 | $659K | <0.1% | New |
| BCYC Bicycle Therapeutics plc | 190,065 | $580K | <0.1% | Reduced −0% |
| PLRX Pliant Therapeutics, Inc. | 888,068 | $551K | <0.1% | Reduced −0% |
| SVRA Savara Inc. | 92,214 | $480K | <0.1% | Reduced −55% |
| LPCN Lipocine Inc. | 293,795 | $441K | <0.1% | Reduced −0% |
| PACB Pacific Biosciences of California, Inc. | 228,007 | $401K | <0.1% | New |
| ASMB Assembly Biosciences, Inc. | 16,510 | $371K | <0.1% | Unchanged |
| RVP Retractable Technologies, Inc. | 580,919 | $348K | <0.1% | Unchanged |
| DNA Ginkgo Bioworks Holdings, Inc. | 37,227 | $305K | <0.1% | New |
| SSII SS Innovations International, Inc. | 109,694 | $140K | <0.1% | Reduced −0% |
| EHTH eHealth, Inc. | 404,854 | $139K | <0.1% | Unchanged |
| CUE Cue Biopharma, Inc. | 22,121 | $100K | <0.1% | New |
| PIII P3 Health Partners Inc. | 50,000 | $93K | <0.1% | New |
Sold out in Q3 2026
| Stock | Shares held at Q2 2026 | Worth today |
|---|---|---|
| MRNA Moderna, Inc. | 152,122 | $30.3M |
| LLY Eli Lilly and Company | 20,116 | $27.2M |
| GSK GSK plc | 481,833 | $23.0M |
| AMN AMN Healthcare Services, Inc. | 428,531 | $14.7M |
| HUM Humana Inc. | 31,171 | $11.8M |
| REPL Replimune Group, Inc. | 590,252 | $11.4M |
| PTGX Protagonist Therapeutics, Inc. | 58,504 | $7.3M |
| CELC Celcuity Inc. | 127,931 | $7.2M |
| GKOS Glaukos Corporation | 29,343 | $7.0M |
| NVO Novo Nordisk A/S | 169,227 | $6.6M |
| DFTX Definium Therapeutics, Inc. | 217,185 | $6.4M |
| ELVN Enliven Therapeutics, Inc. | 136,631 | $6.3M |
| CMPS COMPASS Pathways plc | 672,825 | $5.8M |
| NHC National HealthCare Corporation | 22,116 | $4.2M |
| ARQT Arcutis Biotherapeutics, Inc. | 135,355 | $3.7M |
| AGL agilon health, inc. | 37,792 | $3.4M |
| DSGN Design Therapeutics, Inc. | 190,000 | $1.8M |
| SRZN Surrozen, Inc. | 47,777 | $1.5M |
| EVMN Evommune Inc | 174,460 | $1.3M |
| RVMD Revolution Medicines, Inc. | 6,943 | $1.1M |
| ODTX Odyssey Therapeutics, Inc. | 49,658 | $911K |
| ENGN enGene Therapeutics Inc. | 469,584 | $826K |
| AKBA Akebia Therapeutics, Inc. | 427,095 | $180K |
| EYPT EyePoint, Inc. | 297,735 | $79K |
| AVTX Avalo Therapeutics, Inc. | 10,000 | $68K |
| KPTIQ Karyopharm Therapeutics Inc. | 276,174 | $9K |